Cardiosource PowerPoint PPT Presentations

All Time
Show:
Recommended
Sort by:
Cardiosource em Portugu PowerPoint PPT Presentation
Cardiosource em Portugu - Cardiosource em Portugu s Encontre aqui o Resumo das Principais Publica es Cient ficas da Cardiologia e Entrevistas em Portugu s
Cardiosource em Portugu s Encontre aqui o Resumo das Principais Publica es Cient ficas da Cardiologia e Entrevistas em Portugu s
| PowerPoint PPT presentation | free to download
American%20College%20of%20Cardiology%20%20Transforming%20Science%20into%20Quality%20Care%20Alfred%20A.%20Bove,%20MD,%20PhD,%20FACC PowerPoint PPT Presentation
American%20College%20of%20Cardiology%20%20Transforming%20Science%20into%20Quality%20Care%20Alfred%20A.%20Bove,%20MD,%20PhD,%20FACC - Late-breaking Clinical Trials provide the focus for the most influential ... Cardiosource Video News. Clinical Guidelines and Guidelines in Practice ...
Late-breaking Clinical Trials provide the focus for the most influential ... Cardiosource Video News. Clinical Guidelines and Guidelines in Practice ...
| PowerPoint PPT presentation | free to download
Acute Coronary Syndrome Clinical Trial Summary Slides PowerPoint PPT Presentation
Acute Coronary Syndrome Clinical Trial Summary Slides - Acute Coronary Syndrome Clinical Trial Summary Slides Acute Coronary Syndrome Clinical Trial Summary Slides * www.cardiosource.com A to Z: Phase Z Death/MI/stroke ...
Acute Coronary Syndrome Clinical Trial Summary Slides Acute Coronary Syndrome Clinical Trial Summary Slides * www.cardiosource.com A to Z: Phase Z Death/MI/stroke ...
| PowerPoint PPT presentation | free to view
CABG Clinical Trial Summary Slides PowerPoint PPT Presentation
CABG Clinical Trial Summary Slides - CABG Clinical Trial Summary Slides CABG Clinical Trial Summary Slides * www.cardiosource.com Amiodarone Prophylaxis for Atrial Fibrillation after CABG AF p
CABG Clinical Trial Summary Slides CABG Clinical Trial Summary Slides * www.cardiosource.com Amiodarone Prophylaxis for Atrial Fibrillation after CABG AF p
| PowerPoint PPT presentation | free to view
Science to Practice: The ACC Tapestry PowerPoint PPT Presentation
Science to Practice: The ACC Tapestry - To advocate for quality cardiovascular care through ... Data incentive = change. More. www.acc.org. www.cardiosource.org. janetwright@sbcglobal.net ...
To advocate for quality cardiovascular care through ... Data incentive = change. More. www.acc.org. www.cardiosource.org. janetwright@sbcglobal.net ...
| PowerPoint PPT presentation | free to download
ABIM PowerPoint PPT Presentation
ABIM - ABIM s MOC Changes How to Deliver the Message to ACC s Members and Constituents Developed for members of ACC Boards, Committees, Councils and Other Messengers
ABIM s MOC Changes How to Deliver the Message to ACC s Members and Constituents Developed for members of ACC Boards, Committees, Councils and Other Messengers
| PowerPoint PPT presentation | free to view
National Cardiometabolic Health Initiatives PowerPoint PPT Presentation
National Cardiometabolic Health Initiatives - National Cardiometabolic Health Initiatives Laurence S. Sperling, M.D., FACC, FACP,FAHA Professor of Medicine (Cardiology) Director- Center for Heart Disease Prevention
National Cardiometabolic Health Initiatives Laurence S. Sperling, M.D., FACC, FACP,FAHA Professor of Medicine (Cardiology) Director- Center for Heart Disease Prevention
| PowerPoint PPT presentation | free to download
ACC and the Physician Payments Sunshine Act PowerPoint PPT Presentation
ACC and the Physician Payments Sunshine Act - ACC and the Physician Payments Sunshine Act Today, we ll be discussing the recently issued final regulation implementing the Physician Payment Sunshine Act, ACC s ...
ACC and the Physician Payments Sunshine Act Today, we ll be discussing the recently issued final regulation implementing the Physician Payment Sunshine Act, ACC s ...
| PowerPoint PPT presentation | free to download
Adults with Congenital Heart Disease: Whats Needed PowerPoint PPT Presentation
Adults with Congenital Heart Disease: Whats Needed - Adults with Congenital Heart Disease: What's Needed. Grace Pei-Wen Chen, MD ... fellows, many expressed a need for resources in adult congenital heart diseases ...
Adults with Congenital Heart Disease: What's Needed. Grace Pei-Wen Chen, MD ... fellows, many expressed a need for resources in adult congenital heart diseases ...
| PowerPoint PPT presentation | free to view
MOC Part IV Self Directed PIM: Your Guide To Making It Happen PowerPoint PPT Presentation
MOC Part IV Self Directed PIM: Your Guide To Making It Happen - MOC Part IV Self Directed PIM: Your Guide To Making It Happen Joseph P. Drozda Jr., MD, FACC Mercy Health Richard J. Kovacs, MD, FACC Krannert Institute of Cardiology
MOC Part IV Self Directed PIM: Your Guide To Making It Happen Joseph P. Drozda Jr., MD, FACC Mercy Health Richard J. Kovacs, MD, FACC Krannert Institute of Cardiology
| PowerPoint PPT presentation | free to download
Click to add your title PowerPoint PPT Presentation
Click to add your title - Click to add your title
Click to add your title
| PowerPoint PPT presentation | free to download
Antithrombotic Therapy During Percutaneous Coronary Intervention (PCI) PowerPoint PPT Presentation
Antithrombotic Therapy During Percutaneous Coronary Intervention (PCI) - Antithrombotic Therapy During Percutaneous Coronary Intervention (PCI) James Lin, DO Internal Medicine Resident May 3, 2006.
Antithrombotic Therapy During Percutaneous Coronary Intervention (PCI) James Lin, DO Internal Medicine Resident May 3, 2006.
| PowerPoint PPT presentation | free to view
Caroline Chang PowerPoint PPT Presentation
Caroline Chang - The information and opinions expressed in this presentation are only one view of ... http://www.nlm.nih.gov/medlineplus/tutorials/clinicaltrials/hc019101.html ...
The information and opinions expressed in this presentation are only one view of ... http://www.nlm.nih.gov/medlineplus/tutorials/clinicaltrials/hc019101.html ...
| PowerPoint PPT presentation | free to view
Exercise Testing PowerPoint PPT Presentation
Exercise Testing - Predicted Values for Exercise Hemodynamics (Hossack and Bruce, 1981) - Women ... and exercise capacity. Prognostic value of decreased exercise capacity and ...
Predicted Values for Exercise Hemodynamics (Hossack and Bruce, 1981) - Women ... and exercise capacity. Prognostic value of decreased exercise capacity and ...
| PowerPoint PPT presentation | free to view
iPod The MegaVCR: Media and More in a Pocket PowerPoint PPT Presentation
iPod The MegaVCR: Media and More in a Pocket - iPod The MegaVCR: Media and More in a Pocket
iPod The MegaVCR: Media and More in a Pocket
| PowerPoint PPT presentation | free to view
Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATelet Inhibition and patient Outcomes trial PowerPoint PPT Presentation
Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATelet Inhibition and patient Outcomes trial - STEMI Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATelet Inhibition and patient Outcomes trial Outcomes in patients with ...
STEMI Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATelet Inhibition and patient Outcomes trial Outcomes in patients with ...
| PowerPoint PPT presentation | free to download
ACC Goals 2006: An Overview - Advocacy, Education and Quality Priorities PowerPoint PPT Presentation
ACC Goals 2006: An Overview - Advocacy, Education and Quality Priorities - Cardiology cuts = over $150 million, mostly in echo color doppler flow, nuclear and MR ... Olympia Day and the Demise of HB 2310. Pa - State Legislation ...
Cardiology cuts = over $150 million, mostly in echo color doppler flow, nuclear and MR ... Olympia Day and the Demise of HB 2310. Pa - State Legislation ...
| PowerPoint PPT presentation | free to download
Safety and Efficacy of Commercially Available Ultrasound Contrast Agents in the Clinical Setting PowerPoint PPT Presentation
Safety and Efficacy of Commercially Available Ultrasound Contrast Agents in the Clinical Setting - Safety and Efficacy of Commercially Available Ultrasound Contrast Agents in the Clinical Setting
Safety and Efficacy of Commercially Available Ultrasound Contrast Agents in the Clinical Setting
| PowerPoint PPT presentation | free to download
ABMS/ABIM and ABIM Maintenance of Certification (MOC) for Cardiologists PowerPoint PPT Presentation
ABMS/ABIM and ABIM Maintenance of Certification (MOC) for Cardiologists - ABMS/ABIM and ABIM Maintenance of Certification (MOC) for Cardiologists John Gordon Harold, MD, FACC Chair-Elect, ACC Board of Governors Member, Board of Directors
ABMS/ABIM and ABIM Maintenance of Certification (MOC) for Cardiologists John Gordon Harold, MD, FACC Chair-Elect, ACC Board of Governors Member, Board of Directors
| PowerPoint PPT presentation | free to download
Seung-Jung Park, MD, PhD, PowerPoint PPT Presentation
Seung-Jung Park, MD, PhD, - Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation A Pooled Analysis of the REAL-LATE and the ZEST-LATE Trial Seung-Jung Park, MD, PhD,
Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation A Pooled Analysis of the REAL-LATE and the ZEST-LATE Trial Seung-Jung Park, MD, PhD,
| PowerPoint PPT presentation | free to download
Cholesterol, Cholesterol Therapies, and Cholesterol Guidelines PowerPoint PPT Presentation
Cholesterol, Cholesterol Therapies, and Cholesterol Guidelines - ... Effects Concomitant Use of Meds Verapamil, Amiodarone Nefazadone HIV protease inhibitors Macrolide antibiotics Antifungal azoles** Cyclosporine Nicotinic ...
... Effects Concomitant Use of Meds Verapamil, Amiodarone Nefazadone HIV protease inhibitors Macrolide antibiotics Antifungal azoles** Cyclosporine Nicotinic ...
| PowerPoint PPT presentation | free to view
Folie 1 PowerPoint PPT Presentation
Folie 1 - Excess cardiovascular mortality in patients with peripheral arterial disease in primary care: 5-year results of the getABI Study Diehm C, Trampisch HJ, Holland-Letz T ...
Excess cardiovascular mortality in patients with peripheral arterial disease in primary care: 5-year results of the getABI Study Diehm C, Trampisch HJ, Holland-Letz T ...
| PowerPoint PPT presentation | free to view
Using the ICD Registry to Evaluate Practice Patterns and Improve Quality Overview of the Development of the ICD Registry PowerPoint PPT Presentation
Using the ICD Registry to Evaluate Practice Patterns and Improve Quality Overview of the Development of the ICD Registry - ... Secondary endpoint Survival probability at 3 and 5 ... Device therapy follow-up Every 3 months for a minimum of 3 years Adjudication process Data combined ...
... Secondary endpoint Survival probability at 3 and 5 ... Device therapy follow-up Every 3 months for a minimum of 3 years Adjudication process Data combined ...
| PowerPoint PPT presentation | free to download
Predictors of Acute, Subacute and Late Stent Thrombosis After Acute MI Primary Angioplasty in the Horizons AMI Trial PowerPoint PPT Presentation
Predictors of Acute, Subacute and Late Stent Thrombosis After Acute MI Primary Angioplasty in the Horizons AMI Trial - Predictors of Acute, Subacute and Late Stent Thrombosis After Acute MI Primary Angioplasty in the Horizons AMI Trial George D. Dangas, Alexandra J. Lansky,
Predictors of Acute, Subacute and Late Stent Thrombosis After Acute MI Primary Angioplasty in the Horizons AMI Trial George D. Dangas, Alexandra J. Lansky,
| PowerPoint PPT presentation | free to download
ECLIPSE Trial: Ensure PowerPoint PPT Presentation
ECLIPSE Trial: Ensure - ... sheath checking for pulsatile flow Retract while compressing green cowling to secure Retract sheath & device until non-pulsatile flow Indicator window changes ...
... sheath checking for pulsatile flow Retract while compressing green cowling to secure Retract sheath & device until non-pulsatile flow Indicator window changes ...
| PowerPoint PPT presentation | free to download
Is There a Critical Value of Daily Atrial Tachyarrhythmia Burden from Device Diagnostics that Raises Stroke Risk? The TRENDS Study PowerPoint PPT Presentation
Is There a Critical Value of Daily Atrial Tachyarrhythmia Burden from Device Diagnostics that Raises Stroke Risk? The TRENDS Study - Title: The SAVE-PACe Trial Search AV Extension and Managed Ventricular Pacing for Promoting Atrioventricular Conduction Author: Information Systems
Title: The SAVE-PACe Trial Search AV Extension and Managed Ventricular Pacing for Promoting Atrioventricular Conduction Author: Information Systems
| PowerPoint PPT presentation | free to download
The Relative Safety and Efficacy of Clopidogrel in Women and Men: A Sex-Specific Meta-Analysis PowerPoint PPT Presentation
The Relative Safety and Efficacy of Clopidogrel in Women and Men: A Sex-Specific Meta-Analysis - Title: Underuse of Aspirin in Postmenopausal Women with Cardiovascular Disease: The Women s Health Initiative Author: CHP Last modified by: builder
Title: Underuse of Aspirin in Postmenopausal Women with Cardiovascular Disease: The Women s Health Initiative Author: CHP Last modified by: builder
| PowerPoint PPT presentation | free to view
A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque PowerPoint PPT Presentation
A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque - A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque. Gregg W. Stone, MD
A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque. Gregg W. Stone, MD
| PowerPoint PPT presentation | free to download
Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation: Results of the CABANA Pilot Study PowerPoint PPT Presentation
Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation: Results of the CABANA Pilot Study - Antiarrhythmic Drug Therapy for Atrial Fibrillation: Results of the CABANA Pilot Study Douglas L. Packer, Kerry L. Lee, Daniel B. Mark, Kristi H. Monahan,
Antiarrhythmic Drug Therapy for Atrial Fibrillation: Results of the CABANA Pilot Study Douglas L. Packer, Kerry L. Lee, Daniel B. Mark, Kristi H. Monahan,
| PowerPoint PPT presentation | free to download
Revascularization Treatment for the Individual With PAD: The Symptomatic Leg PowerPoint PPT Presentation
Revascularization Treatment for the Individual With PAD: The Symptomatic Leg - Title: ACC/AHA PAD Guideline Slide Set-ACC'06 Author: Alan Hirsch Last modified by: builder Created Date: 9/23/2005 2:45:20 PM Document presentation format
Title: ACC/AHA PAD Guideline Slide Set-ACC'06 Author: Alan Hirsch Last modified by: builder Created Date: 9/23/2005 2:45:20 PM Document presentation format
| PowerPoint PPT presentation | free to view
Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-controlled Trials: The Cross Trial Safety Analysis PowerPoint PPT Presentation
Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-controlled Trials: The Cross Trial Safety Analysis - Cardiovascular Risk ... trial results led to stopping drug in that trial and in 5 ... or whether non-selective non-steroidal anti-inflammatory agents would be ...
Cardiovascular Risk ... trial results led to stopping drug in that trial and in 5 ... or whether non-selective non-steroidal anti-inflammatory agents would be ...
| PowerPoint PPT presentation | free to view
Personalized Cardiovascular Medicine: Where We Stand Now, PowerPoint PPT Presentation
Personalized Cardiovascular Medicine: Where We Stand Now, - Personalized Cardiovascular Medicine: Where We Stand Now, and The Road Ahead Kiran Musunuru, MD, PhD, MPH Jeffrey S Berger, MD, MS Geoffrey S Ginsburg, MD, PhD, FACC
Personalized Cardiovascular Medicine: Where We Stand Now, and The Road Ahead Kiran Musunuru, MD, PhD, MPH Jeffrey S Berger, MD, MS Geoffrey S Ginsburg, MD, PhD, FACC
| PowerPoint PPT presentation | free to download
Young-Hak Kim, MD, PhD PowerPoint PPT Presentation
Young-Hak Kim, MD, PhD - Preventive Strategies of REnal Insufficiency in Patients with Diabetes Undergoing InterVENTion or Arteriography: The PREVENT trial Young-Hak Kim, MD, PhD
Preventive Strategies of REnal Insufficiency in Patients with Diabetes Undergoing InterVENTion or Arteriography: The PREVENT trial Young-Hak Kim, MD, PhD
| PowerPoint PPT presentation | free to download
Seung-Jung Park, MD, PhD PowerPoint PPT Presentation
Seung-Jung Park, MD, PhD - Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions:
Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions:
| PowerPoint PPT presentation | free to download
Home Health Monitoring Reduces Cardiovascular Disease Risk In Medically Underserved Communities PowerPoint PPT Presentation
Home Health Monitoring Reduces Cardiovascular Disease Risk In Medically Underserved Communities - Home Health Monitoring Reduces Cardiovascular Disease Risk In Medically Underserved Communities Alfred A. Bove, MD, PhD Temple Univ. Medical School
Home Health Monitoring Reduces Cardiovascular Disease Risk In Medically Underserved Communities Alfred A. Bove, MD, PhD Temple Univ. Medical School
| PowerPoint PPT presentation | free to download
Diabetes Mellitus Clinical Trial Summary Slides PowerPoint PPT Presentation
Diabetes Mellitus Clinical Trial Summary Slides - Carotid IMT was evaluated at baseline, 12 weeks and 24 weeks. Results Peripheral edema in pioglitazone group (n=21 vs 2, p
Carotid IMT was evaluated at baseline, 12 weeks and 24 weeks. Results Peripheral edema in pioglitazone group (n=21 vs 2, p
| PowerPoint PPT presentation | free to view
Duality of interests PowerPoint PPT Presentation
Duality of interests - ... at low doses with and without ASA is equivalent in reducing HR vs Atenolol is equivalent in modifying lipids vs. simvastatin alone is equivalent in suppressing ...
... at low doses with and without ASA is equivalent in reducing HR vs Atenolol is equivalent in modifying lipids vs. simvastatin alone is equivalent in suppressing ...
| PowerPoint PPT presentation | free to download
ACC/AHA Classification of Care Metrics PowerPoint PPT Presentation
ACC/AHA Classification of Care Metrics - Title: Approach to Medical Therapy, PTCA, or Surgery in the Diabetic Patient Author: Owner Last modified by: Owner Document presentation format: 35mm Slides
Title: Approach to Medical Therapy, PTCA, or Surgery in the Diabetic Patient Author: Owner Last modified by: Owner Document presentation format: 35mm Slides
| PowerPoint PPT presentation | free to download
Coronary Artery Disease Clinical Trial Summary Slides PowerPoint PPT Presentation
Coronary Artery Disease Clinical Trial Summary Slides - Coronary Artery Disease Clinical Trial Summary Slides ... (from 3.68 to 2.40 mmol/L) Peripheral edema was highest in combination group (Figure) ...
Coronary Artery Disease Clinical Trial Summary Slides ... (from 3.68 to 2.40 mmol/L) Peripheral edema was highest in combination group (Figure) ...
| PowerPoint PPT presentation | free to view
Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research` PowerPoint PPT Presentation
Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research` - Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research` Rury R. Holman, MB, ChB, FRCP Professor of Diabetic Medicine Director, Diabetes Trials Unit ...
Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research` Rury R. Holman, MB, ChB, FRCP Professor of Diabetic Medicine Director, Diabetes Trials Unit ...
| PowerPoint PPT presentation | free to download
CHAMPION PLATFORM PowerPoint PPT Presentation
CHAMPION PLATFORM - Deepak L. Bhatt, MD, MPH, A. Michael Lincoff, MD, C. Michael Gibson, MS, MD, Gregg W. Stone, MD, Steven McNulty, MS, Gilles Montalescot, MD, PhD,
Deepak L. Bhatt, MD, MPH, A. Michael Lincoff, MD, C. Michael Gibson, MS, MD, Gregg W. Stone, MD, Steven McNulty, MS, Gilles Montalescot, MD, PhD,
| PowerPoint PPT presentation | free to download
Short-term effects of Tolvaptan in acute decompensated heart failure. Understanding the results of EVEREST. PowerPoint PPT Presentation
Short-term effects of Tolvaptan in acute decompensated heart failure. Understanding the results of EVEREST. - Title: Slide 1 Author: chrisz Last modified by: Producer Created Date: 10/27/2006 1:45:46 PM Document presentation format: On-screen Show Company: OTSUKA
Title: Slide 1 Author: chrisz Last modified by: Producer Created Date: 10/27/2006 1:45:46 PM Document presentation format: On-screen Show Company: OTSUKA
| PowerPoint PPT presentation | free to view
Effects of Clinical Characteristics and Treatments on Gender Difference in Outcomes after Acute Myocardial Infarction. PowerPoint PPT Presentation
Effects of Clinical Characteristics and Treatments on Gender Difference in Outcomes after Acute Myocardial Infarction. - Effects of Clinical Characteristics and Treatments on Gender Difference in Outcomes after Acute Myocardial Infarction. A propensity score-matched analysis
Effects of Clinical Characteristics and Treatments on Gender Difference in Outcomes after Acute Myocardial Infarction. A propensity score-matched analysis
| PowerPoint PPT presentation | free to download
M Webster PowerPoint PPT Presentation
M Webster - Title: Slide 1 Author: Barbara Semb Last modified by: localuser Created Date: 2/8/2004 10:52:41 PM Document presentation format: On-screen Show Company
Title: Slide 1 Author: Barbara Semb Last modified by: localuser Created Date: 2/8/2004 10:52:41 PM Document presentation format: On-screen Show Company
| PowerPoint PPT presentation | free to download
Bosentan for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) and post-pulmonary endarterectomy pulmonary hypertension PowerPoint PPT Presentation
Bosentan for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) and post-pulmonary endarterectomy pulmonary hypertension - PAH is divided into different aetiologies, one of these is PAH associated with CHD (PAH-CHD). This training module focuses on this sub-classification of PAH.
PAH is divided into different aetiologies, one of these is PAH associated with CHD (PAH-CHD). This training module focuses on this sub-classification of PAH.
| PowerPoint PPT presentation | free to view
Effect of Rosuvastatin Therapy on Coronary Artery Stenosis Assessed by Quantitative Coronary Angiography in ASTEROID PowerPoint PPT Presentation
Effect of Rosuvastatin Therapy on Coronary Artery Stenosis Assessed by Quantitative Coronary Angiography in ASTEROID - Effect of Rosuvastatin Therapy on Coronary Artery Stenosis Assessed by Quantitative Coronary Angiography in ASTEROID CM Ballantyne,1 JS Raichlen,2 SJ Nicholls,3 R Erbel,4
Effect of Rosuvastatin Therapy on Coronary Artery Stenosis Assessed by Quantitative Coronary Angiography in ASTEROID CM Ballantyne,1 JS Raichlen,2 SJ Nicholls,3 R Erbel,4
| PowerPoint PPT presentation | free to view


Home About Us Terms and Conditions Privacy Policy Contact Us
Copyright 2025 CrystalGraphics, Inc. — All rights Reserved. PowerShow.com is a trademark of CrystalGraphics, Inc.
cardiosource — Search results on PowerShow.com